Stay updated on Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The study record describes a completed Phase 2 trial of oral azacitidine combined with pembrolizumab for metastatic melanoma, including its two treatment groups, participant criteria, and measured outcomes. It also lists the study’s dates, locations, and investigators.
    Difference
    61%
    Check dated 2026-11-07T12:42:23.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov revision as v3.8.0 instead of v3.7.2.
    Difference
    0.3%
    Check dated 2026-10-31T13:33:48.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    An NIH site-wide banner announces updates and FAQs about a terminology transition, stating that “Super Intelligence” is replacing “Artificial Intelligence” in some NIH content. The study page itself continues to show a 403 error.
    Difference
    1%
    Check dated 2026-10-24T13:09:01.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:30:22.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T14:07:56.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating the record is inaccessible; the screen shows the 403 header and standard error-page navigation.
    Difference
    21%
    Check dated 2026-09-19T20:10:27.000Z thumbnail image

Stay in the know with updates to Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.